CN Patent

CN116726045B — 一种氟雷拉纳组合物

Assigned to Chongqing Hanpei Biotechnology Co ltd · Expires 2024-03-19 · 2y expired

What this patent protects

本发明公开了一种氟雷拉纳组合物，其特征在于：含有葡庚糖酐铁溶液和氟雷拉纳，所述氟雷拉纳分散在葡庚糖酐铁溶液中，用于络合葡庚糖酐铁的葡庚糖酐酸的分子量分布范围为2000‑4000。可实现氟雷拉纳做成注射剂，并且在给药的同时补铁，提高免疫力。

USPTO Abstract

本发明公开了一种氟雷拉纳组合物，其特征在于：含有葡庚糖酐铁溶液和氟雷拉纳，所述氟雷拉纳分散在葡庚糖酐铁溶液中，用于络合葡庚糖酐铁的葡庚糖酐酸的分子量分布范围为2000‑4000。可实现氟雷拉纳做成注射剂，并且在给药的同时补铁，提高免疫力。

Drugs covered by this patent

Patent Metadata

Patent number
CN116726045B
Jurisdiction
CN
Classification
—
Expires
2024-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Hanpei Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.